CUSIP: 002120103
Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,344,591
-
Share change
-
+6,231,503
-
Total reported value
-
$87,589,300
-
Price per share
-
$5.05
-
Number of holders
-
36
-
Value change
-
+$31,518,229
-
Number of buys
-
14
-
Number of sells
-
8
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2017
-
Previous quarter:
Q2 2017
Recent filing periods for CUSIP 002120103:
Institutional Holders of ATYR PHARMA INC - COM (LIFE) as of Q3 2017
As of 30 Sep 2017,
ATYR PHARMA INC - COM (LIFE) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,344,591 shares.
The largest 10 holders included
EcoR1 Capital, LLC, FMR LLC, Redmile Group, LLC, Polaris Venture Management Co. V, L.L.C., Viking Global Investors LP, Alyeska Investment Group, L.P., BlackRock Inc., Rock Springs Capital Management LP, VANGUARD GROUP INC, and Artal Group S.A..
This page lists
36
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.